However , this difference was not associated with greater clinical improvement , lesser diuretic requirements , or fewer hospitalizations for heart failure ( 11.1 % for amiodarone and 13.6 % for placebo group ; overall relative risk in the amiodarone group , 0.81 [ 95 % CI , 0.56 to 1.10 ] , P = .18 ) .
